¿La vacuna de refuerzo bivalente contra el COVID-19 contribuye a prevenir el contagio?
Posts en Español Vaccines
Aparna Kumar, PhD CRNP MPH
Respuesta corta: ¡sí! La vacuna de refuerzo bivalente brinda protección adicional contra infecciones sintomáticas de COVID-19 para personas que habían recibido previamente las primeras vacunas de ARNm. El CDC acaba de publicar un nuevo estudio que analizó la eficacia del refuerzo bivalente para prevenir infecciones sintomáticas de COVID-19 en comparación con la vacuna monovalente, que Read more…
May 11, 2023
What do we know about the new RSV vaccine for pregnant people? Is it safe?
Infectious Diseases Vaccines
Sara Gorman, PhD, MPH
A: The new respiratory syncytial virus (RSV) vaccine will be given to pregnant people and passes on RSV immunity to their newborns. RSV is a serious respiratory infection that can cause hospitalization and death in infants. Clinical trials showed a good safety profile. About RSV and recent outbreaks RSV is a common respiratory infection that Read more…
Respuesta corta: ¡sí! La vacuna de refuerzo bivalente brinda protección adicional contra infecciones sintomáticas de COVID-19 para personas que habían recibido previamente las primeras vacunas de ARNm. El CDC acaba de publicar un nuevo estudio que analizó la eficacia del refuerzo bivalente para prevenir infecciones sintomáticas de COVID-19 en comparación con la vacuna monovalente, que Read more…
What do we know about the new RSV vaccine for pregnant people? Is it safe?
Infectious Diseases Vaccines
Sara Gorman, PhD, MPH
A: The new respiratory syncytial virus (RSV) vaccine will be given to pregnant people and passes on RSV immunity to their newborns. RSV is a serious respiratory infection that can cause hospitalization and death in infants. Clinical trials showed a good safety profile. About RSV and recent outbreaks RSV is a common respiratory infection that Read more…
A: The new respiratory syncytial virus (RSV) vaccine will be given to pregnant people and passes on RSV immunity to their newborns. RSV is a serious respiratory infection that can cause hospitalization and death in infants. Clinical trials showed a good safety profile. About RSV and recent outbreaks RSV is a common respiratory infection that Read more…
Get a discounted subscriber rate until Sept 11
Please become a Paid Subscriber to our twice-weekly Substack email newsletter. Enjoy a 10% discount on the $50 yearly rate until September 11, 2026.
Be part of the movement to ensure Those Nerdy Girls can continue to be a trusted messenger of health information for all. We need you in order to sustain the work.
